Development of Th1 imprints to rBCG expressing a foreign protein: implications for vaccination against HIV-1 and diverse influenza strains.

Abstract

We demonstrate here that immunizing naïve mice with low numbers of recombinant Bacille Calmette-Guérin (rBCG) expressing beta-galactosidase (beta-gal) generates predominant Th1 responses to both BCG and beta-gal whereas infection with high numbers generates a mixed Th1/Th2 response to both BCG and beta-gal. Furthermore, the Th1 response to both BCG and beta-gal is stable when mice, pre-exposed to low numbers of rBCG, are challenged four months later with high numbers of rBCG. Thus the Th1/Th2 phenotypes of the immune responses to beta-gal and to BCG are "coherently" regulated. Such rBCG vectors, encoding antigens of pathogens preferentially susceptible to cell-mediated attack, may be useful in vaccinating against such pathogens. We discuss vaccination strategies employing rBCG vectors that are designed to provide protection against diverse influenza strains or numerous variants of HIV-1 and consider what further experiments are essential to explore the possibility of realizing such strategies.

• Authors: Carl Power, Travis W Marfleet, Louis Qualtiere, Wei Xiao, Peter Bretscher
• Journal: Journal of biomedicine & biotechnology (J Biomed Biotechnol) Vol. 2010 Pg. 591348 ( 2010) ISSN: 1110-7251 [Electronic] United States
• PMID: 20625498 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)

Chemical References

• Interleukin-4
• Interferon-gamma
• beta-Galactosidase

Topics

• Animals
• Antibody Formation (immunology)
• Dose-Response Relationship, Immunologic
• Female
• HIV-1 (immunology)
• Immunity (immunology)
• Injections, Intradermal
• Injections, Intravenous
• Interferon-gamma (biosynthesis)
• Interleukin-4 (biosynthesis)
• Mice
• Mice, Inbred BALB C
• Mycobacterium bovis (genetics, immunology)
• Orthomyxoviridae (classification, immunology)
• Recombination, Genetic
• Th1 Cells (immunology)
• Vaccination
• beta-Galactosidase (biosynthesis, genetics, immunology)